Operating CF
$20.48B
Capex
−$6.90B
Free Cash Flow
$13.58B
FCF Margin
+66.3%
Cash flow waterfall for Eli Lilly (LLY) — TTM through Q1 2026
Free cash flow: $13.58B
Cash flow breakdown for Eli Lilly (LLY) — TTM through Q1 2026
| Line item | Amount | Running total |
|---|---|---|
| Operating Cash Flow | $20.48B | $20.48B |
| Capital Expenditure | −$6.90B | $13.58B |
| Free Cash Flow | $13.58B | $13.58B |
| Acquisitions | −$1.72B | $11.86B |
| Other Investing | −$2.92B | $8.94B |
| Share Buybacks | −$5.26B | $3.68B |
| Dividends Paid | −$5.59B | −$1.91B |
| Net Debt Change | $4.46B | $2.56B |
| Other Financing & FX | −$369.60M | $2.19B |
| Net Cash Increase | $2.19B | $2.19B |
- Operating Cash Flow$20.48B
- Capital Expenditure−$6.90B
- Free Cash Flow$13.58B
- Acquisitions−$1.72B
- Other Investing−$2.92B
- Share Buybacks−$5.26B
- Dividends Paid−$5.59B
- Net Debt Change$4.46B
- Other Financing & FX−$369.60M
- Net Cash Increase$2.19B
Want to see what drove the FCF change?Free Cash Flow Bridge
Frequently asked questions
Data & methodology
Eli Lilly (LLY) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement